As a member of RUNX family, RUNX2 is a critical regulator and master organizer in bone development and several malignances, including lung cancer, breast cancer, pancreatic cancer, liver, prostate cancer, ovarian cancer, etc. [30,31]. Here, RUNX2 is linked to ovarian carcinoma.